FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder - FDA Press Releases

FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder

from Food and Drug Administration--Press Releases https://ift.tt/2Mu9W53
via IFTTT